Home > Publications database > CXCL9 predicts Severity at Onset of Chronic Graft-Versus-Host Disease. > print

001     153101
005     20240229123039.0
024 7 _ |a 10.1097/TP.0000000000003108
|2 doi
024 7 _ |a pmid:31929430
|2 pmid
024 7 _ |a 0041-1337
|2 ISSN
024 7 _ |a 1534-0608
|2 ISSN
024 7 _ |a 1534-6080
|2 ISSN
037 _ _ |a DKFZ-2020-00183
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Giesen, Nicola
|0 P:(DE-He78)8dc0876dc3ed1862337d98842984727d
|b 0
|e First author
|u dkfz
245 _ _ |a CXCL9 predicts Severity at Onset of Chronic Graft-Versus-Host Disease.
260 _ _ |a [s.l.]
|c 2020
|b Ovid
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1605621747_12563
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:A360#2020 Nov;104(11):2354-2359
520 _ _ |a CXCL9 predicts Severity at Onset of Chronic Graft-Versus-Host Disease.
536 _ _ |a 311 - Signalling pathways, cell and tumor biology (POF3-311)
|0 G:(DE-HGF)POF3-311
|c POF3-311
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Schwarzbich, Mark-Alexander
|b 1
700 1 _ |a Dischinger, Katharina
|b 2
700 1 _ |a Becker, Natalia
|0 P:(DE-He78)ecb33fb615e08035fdcefcaebfdff8f0
|b 3
700 1 _ |a Hummel, Manuela
|0 P:(DE-He78)fae4f3c76bbbd2fc21dd920b46945d42
|b 4
700 1 _ |a Benner, Axel
|0 P:(DE-He78)e15dfa1260625c69d6690a197392a994
|b 5
|u dkfz
700 1 _ |a Radujkovic, Aleksandar
|b 6
700 1 _ |a Müller-Tidow, Carsten
|b 7
700 1 _ |a Dreger, Peter
|b 8
700 1 _ |a Luft, Thomas
|b 9
773 _ _ |a 10.1097/TP.0000000000003108
|g p. 1 -
|0 PERI:(DE-600)2035395-9
|n 11
|p 2354-2359
|t Transplantation
|v 104
|y 2020
|x 0041-1337
909 C O |o oai:inrepo02.dkfz.de:153101
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)8dc0876dc3ed1862337d98842984727d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)ecb33fb615e08035fdcefcaebfdff8f0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)fae4f3c76bbbd2fc21dd920b46945d42
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)e15dfa1260625c69d6690a197392a994
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-311
|2 G:(DE-HGF)POF3-300
|v Signalling pathways, cell and tumor biology
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2020
915 _ _ |a Allianz-Lizenz
|0 StatID:(DE-HGF)0410
|2 StatID
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b TRANSPLANTATION : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 0 _ |0 I:(DE-He78)A360-20160331
|k A360
|l KKE Mol. Hämatologie/Onkologie
|x 0
920 1 _ |0 I:(DE-He78)A360-20160331
|k A360
|l KKE Mol. Hämatologie/Onkologie
|x 0
920 1 _ |0 I:(DE-He78)C060-20160331
|k C060
|l C060 Biostatistik
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)A360-20160331
980 _ _ |a I:(DE-He78)C060-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21